top of page

Boston CEO

October 2025
Boston

Join Longwood Healthcare Leaders this fall as top BioPharma executives convene at the Mandarin Oriental, Boston for off-the-record discussions and top tier networking with BioPharma CEOs, heads of research and development, life science investors, and leading academics.

Rochelle Walensky and Peter Hutt  (2).HEIC
panel klibanski sudarsan dunsire.jpg
Boston CEO Venue.webp

2024 Co-hosts

Boston CEO is co-hosted alongside leaders in the industry.

2024 Featured Speakers

Academia & Research

Regulatory & Public Policy

R&D Leaders

BioPharma CEOs

BD & Strategy

Investor Perspectives 

Venue

Longwood Healthcare Leaders Boston CEO
is held at the Mandarin Oriental, Boston

776 Boylston St, Boston, MA 02199

Agenda

Day 1

7:00 am 
REGISTRATION & NETWORKING BREAKFAST
 
7:30 am
LONGWOOD FUND INTRODUCTION
Vikas Goyal, Venture Partner, Longwood Fund


8:00 am
ACCELERATING THE TRANSLATION OF SCIENCE INTO MEDICINE
Sandra GlucksmannCEO, Sensorium Therapeutics

Theresa Heah, CEO, Paratus Sciences

Sek Kathiresan, CEO, Verve Therapeutics
Mathai Mammen, CEO, FogPharma
Moderator:
John Lepore, CEO, ProFound Therapeutics 
 

8:30 am 
R&D COLLABORATION
Susan HockfieldPresident Emerita, MIT

Anne Klibanski, CEO, Mass General Brigham
Fiona Mack, VP & Head, Co.Lab Cambridge, Bayer

Trevor Martin, CEO, Mammoth Biosciences
Moderator: Aaron Mitchell, Managing Partner, Global Research & Development Lead, ZS Associates
 

9:00 am
REGULATORY & INDUSTRY ROUNDTABLE

Ted Love, Chair, BIO

Peter Marks, Director, CBER, FDA

Moderator: Christoph Westphal, General Partner, Longwood Fund 
 

9:20 am 
FIRESIDE CHAT
Ed MarkeySenator, Commonwealth of Massachusetts

Michelle Wu, Mayor, City of Boston

Moderator: Christoph Westphal, General Partner, Longwood Fund 


9:40 am 
NETWORKING BREAK
 
10:10 am 
COMPANY FORMATION: BUILDING A BIOTECH              
Marion Dorsch, CSO, Atavistik Bio

Dipal DoshiCEO, Entrada Therapeutics

Chris Loose, CEO, Progentos Therapeutics
Wendye Robbins, CEO, Incendia Therapeutics 

Moderator: Caroline Loew, CEO, Mural Oncology
 

10:40 am 
INNOVATION IN CLINICAL TRIALS

Brian Alexander, SVP, Pharma R&D, Roche Genentech 

Camille Bedrosian, CMO, Amylyx Pharmaceuticals

Ed Kaye, CEO, Stoke Therapeutics

Gilmore O’Neill, CEO, Editas
Moderator: Jim Anthony, President, Parexel Biotech
 

11:10 am 
EXPANDING PLATFORM POTENTIAL
Michael AmorosoCEO, Precision Biosciences

Rachel Humphrey, CEO, Normunity 

Cigall Kadoch, Associate Professor, Dana-Farber Cancer Institute & Harvard Medical School

Victoria RichonCEO, Entact Bio

Zhen Su, CEO, Marengo Therapeutic
Moderator: Mike Jahner, VP, Life Sciences, Alliant

 
11:40 am 

GUBERNATORIAL KEYNOTE

Maura Healey, Governor, Commonwealth of Massachusetts

Moderator: Christoph Westphal, General Partner, Longwood Fund

 
12:00 pm 
NETWORKING LUNCHEON
 
1:00 pm 
INNOVATION IN CELL THERAPY

Sharon Benzeno, CCO, Adaptive Biotechnologies
Maurits GeerlingsCEO, NanoCell Therapeutics

Paul LammersBoard Director, Diakonos Oncology
Raj Prasad, CFO, CRISPR Therapeutics 

Moderator: Greg Licholai, Chief Medical & Innovation Officer, ICON
 

1:30 pm 
PREPARING FOR COMMERCIAL DEPLOYMENT
Jack Danilkowicz, SVP, Commercial, Rare Disease, Amgen

Shalabh Gupta, CEO, Unicycive Therapeutics

Rachid Izzar, EVP, Head, Global Product Strategy & Commercialization, Biogen
Deniz Razon, CBO, Servier Pharmaceuticals

Moderator: Leslie Orne, CEO, Trinity Life Sciences

 
2:00 pm 

POLICY IMPACT ON INNOVATION

Kendalle Burlin O’Connell, CEO, MassBio

Priya Singhal, EVP, Head, Development, Biogen 

Skip VirginDistinguished Fellow, AI Drug Discovery & Development, Gates Foundation

Moderator: Louis FogelPrincipal, Fish & Richardson

2:30 pm 

SPOTLIGHT ON BIOMEDICAL INNOVATION

Paola Arlotta, Chair, Stem Cell & Regenerative Biology, Harvard University
Lew Cantley, Professor, Cell Biology, Harvard Medical School 

Samir Hanash, Director, Institute for Cancer Detection and Treatment, MD Anderson Cancer Center
Andrew Lane, Associate Chief, Hematologic Neoplasia, Dana-Farber Cancer Institute
Moderator: Lizzie NgoPrincipal, Longwood Fund


2:50 pm 
NETWORKING BREAK
 

3:20 pm 
IMPROVING HEALTH EQUITY AND PATIENT IMPACT

Anna KazanchyanCEO, Saghmos Therapeutics

Gavin MacBeathCEO, TScan Therapeutics

Deborah MashCEO, DemeRx

Ramona Sequeira, President, Global Portfolio, Takeda 

Moderator: Sharon Suchotliff, Partner, ZS Associates


3:50 pm 
FIRESIDE CHAT
Mary Lynne Hedley, Co-Founder, President & COO, TESARO

John Maraganore, former CEO, Alnylam 

Moderator: Stuart Henderson, Senior Managing Director, Accenture

 
4:10 pm 
ALIGNING PRIORITIES FOR THE PARTNERSHIP
Vanessa Almendro-Navarro, VP, Head of Innovation, Danaher
Paul Biondi, President, Pioneering Medicines

Evan Lippman, Chief Corporate Development & Strategy Officer, Alnylam
Dominique Verhelle, CEO, NextRNA Therapeutics

Moderator: Richard Paulson, CEO, Karyopharm Therapeutics
 

4:40 pm 
STRUCTURING THE SYNDICATE

Miles Gerson, Global Head, Takeda Ventures

Tony HoChief Scientific Officer & Senior Science Partner, Pivotal Life Sciences

Omar KhalilManaging Director, Santé Ventures

Campbell Murray, Senior Partner, Bioluminescence Ventures

Moderator: Lucy LiuPrincipal, Longwood Fund

Day 2

7:00 am 

REGISTRATION & NETWORKING BREAKFAST

7:30 am 

LONGWOOD FUND INTRODUCTION

Aleks Radovic-Moreno, Partner, Longwood Fund

8:00 am 

PHARMA PIPELINE SOURCING

Fawzi Benzaghou, SVP, Global Head, Oncology, Ipsen

Kathy Fernando, SVP, Global Head, Pfizer Ignite 

Pallavi Garg, Head, US Oncology Business Unit, Takeda

John PottageLead Scientific Consultant, INTREPID Alliance
​Moderator: Michelle LongmireCEO, Medable​

8:30 am 

TARGETING GLP-1

David MollerFormer Head, Metabolic Disease R&D, Eli Lilly

Jørgen Petersen, Senior Partner, Novo Holdings

Raymond Stevens, CEO, Structure Therapeutics

Moderator: Kyle Lefkoff, General Partner, Boulder Ventures

8:50 am 

LEVERAGING TECHNOLOGY TO ADVANCE THE PIPELINE

Jason Cole, CEO, SalioGen Therapeutics

Hanadie YousefCEO, Juvena Therapeutics

Kai Wucherpfennig, Chair, Cancer Immunology and Virology, Dana-Farber Cancer Institute

Ashley Zehnder, CEO, Fauna Bio 

Moderator: Chandra Ramanathan, Head, External Innovation, Danaher 

9:20 am 

ACCELERATING DRUG DISCOVERY

Daniel Dornbusch, CEO, Excision BioTherapeutics 

Frank Haluska, CEO, Kestrel Therapeutics 

Jennifer MichaelsonCSO, Cullinan Therapeutics

Brian Safina, CEO, Magnet Biomedicine

Moderator: Harvey Berger, CEO, Kojin Therapeutics

9:50 am 

NETWORKING BREAK 

10:20 am 

TARGETED MERGERS & ACQUSITIONS 

Jeff Capello, former CFO, Biogen

Jessica Chutter, Managing Director, Vice Chair, Biotechnology Investment Banking, Morgan Stanley

Raj Khunkhun, Head, Neuroscience BD, Takeda 

Chris SheldonSVP, Global Head, BD, GSK

Moderator: Philippe Lopes-Fernandes, CBO, Ipsen

10:50 am 

ALIGNING WITH REGULATORY AUTHORITIES

Jessica Ballinger, CEO, Lyndra Therapeutics

Ned BraunsteinEVP, Regulatory Affairs & Global Patient Safety, Regeneron

Peter Hutt, General Counsel (former), FDA

Thomas Lonngren, former Executive Director, EMA

Moderator: DA Gros, CEO, Eledon Therapeutics

11:20 am 

PATIENT-CENTRIC DEVELOPMENT

Craig BunnellCMO, Dana-Farber Cancer Institute

Caroline Kant, CEO, EspeRare Foundation

Sarah Sheikh, Head, Global Development & SVP, Neuroscience, Takeda 

Brandon Turunen, CTO, Solu Therapeutics

Moderator: Ariel Katz, CEO, H1

11:50 am 

FIRESIDE CHAT

Levi GarrawayCMO, Roche Genentech

Robert Plenge, EVP, Chief Research Officer, Head of Research, Bristol Myers Squibb

George YancopoulosPresident & CSO, Regeneron

Bob Weinberg, Founding Member, Whitehead Institute, MIT

Moderator: Christoph Westphal, General Partner, Longwood Fund

12:20 pm 

NETWORKING LUNCHEON

1:00 pm 

DRIVING PRODUCTIVITY IN R&D

Gina Consylman, R&D, CFO & COO, Takeda

Ashley LaknerHead, Oncology, pRED, Roche

Nello Mainolfi, CEO, Kymera

Joanna Stanicka, CEO, Axonis

Moderator: Yiannis Kiachopoulos, CEO, Causaly

1:30 pm 

FIRESIDE CHAT

Alan GarberPresident, Harvard University

Sally Kornbluth, President, MIT

Jim Reddoch, CSO, Royalty Pharma

Moderator: Christoph Westphal, General Partner, Longwood Fund 

1:50 pm 

IDENTIFYING NEXT GENERATION THERAPEUTICS

​Rosana Kapeller, CEO, Rome Therapeutics

Mark RusCEO, Delix Therapeutics

Oliver Rosen, CMO, Akamis Bio

Paul Peter Tak, CEO, Candel Therapeutics 

Moderator: Brian Taylor, CEO, SmartLabs

2:20 pm 

DEVELOPING AN EFFECTIVE BOARD

David DonabedianExecutive Partner, Interim NewCo CEO, Longwood Fund

Nenad Grmusa, CEO, Dem BioPharma

Tamar Thompson, Head, Global Corporate Affairs, Alexion 

Leslie Williams, CEO, hC Bioscience

Moderator: Luba Greenwood, Managing Director, Binney Street Capital, Dana-Farber Cancer Institute

2:50 pm 

NETWORKING BREAK

3:15 pm

NON-PROFIT SPOTLIGHT

Brad Margus, Founder & Volunteer Board Chair, A-T Children’s Project

3:20 pm

FIRESIDE CHAT: PHARMA R&D

Fiona Marshall, President, Biomedical Research, Novartis

Marcus Schindler, CSO & EVP, Research & Early Development, Novo Nordisk 

Co-Moderator: Kailash SwarnaManaging Director, Accenture

Christoph Westphal, General Partner, Longwood Fund 

                                                                                                 

3:40 pm

BIOMANUFACTURING: PLANNING FOR FUTURE SUCCESS 

Al Gianchetti, CEO, XyloCor

Marinna MadridChief Product Officer, CellinoBio

Avi NandiPresident, Cell & Gene Therapy, SK pharmtechco

Hari Pujar, COO, Tessera Therapeutics

Moderator: Andrew Obenshain, CEO, bluebird bio

4:10 pm

THE EVOLVING DEAL-MAKING LANDSCAPE

Jie D’Elia, CEO, SystImmune 

Amanda KaySenior Partner & Chief BD Officer, Flagship Pioneering

Debra Peattie, Managing Partner, SV Investment

Stu Mackey, Global Head, BD, Daiichi Sankyo

Moderator: Bob SilvermanCBO, Turbine Simulated Cell Technologies

4:40 pm

INVESTOR PERSPECTIVES IN ELECTION SEASON

Dean Dimizas, Managing Director, Cambridge Associates

Ansbert Gadicke, Managing Partner, MPM BioImpact

Yigal NochomovitzDirector, SMid Cap Biotech Analyst, Citi Research

Claudine Prowse, Venture Partner, JP Morgan Asset Management 

Moderator: Aleks Radovic-Moreno, Partner, Longwood Fund

5:10 pm 

COCKTAIL RECEPTION

2024 Speaking Faculty

Supporters 

​To learn more about getting involved contact sg@longwoodfund.com

Parexel Biotech Logo Transparent.png
bottom of page